Stocks and Investing
Stocks and Investing
Tue, August 13, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Arthur He Reiterated (ADAP) at Strong Buy and Held Target at $4 on, Aug 13th, 2024
Arthur He of HC Wainwright & Co., Reiterated "Adaptimmune Therapeutics plc" (ADAP) at Strong Buy and Held Target at $4 on, Aug 13th, 2024.
Arthur has made no other calls on ADAP in the last 4 months.
There are 2 other peers that have a rating on ADAP. Out of the 2 peers that are also analyzing ADAP, 0 agree with Arthur's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Arthur
- George Farmer of "Scotiabank" Initiated at Buy and Held Target at $3.15 on, Thursday, May 30th, 2024
- Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Decreased Target to $3 on, Friday, May 17th, 2024
Contributing Sources